| ELI LILLY |
| USA |
| Gesundheit |
| US5324571083 / 858560 |
| LLY (Frankfurt) / LLY (NYSE) |
| FRA:LLY, ETR:LLY, LLY:GR, NYSE:LLY |
| S&P500 |
| https://www.lilly.com/ |
|
Eli Lilly and Company is a leading pharmaceutical company engaged in the discovery, development, manufacture, and sale of human pharmaceutical products. It focuses on innovative medicines addressing critical health needs in areas such as diabetes, on..
>Volltext.. |
| 876441.52 Mio. EUR |
| 909418.07 Mio. EUR |
| 62132.47 Mio. EUR |
| 31143.07 Mio. EUR |
| 21735.77 Mio. EUR |
| 23.92 EUR |
| 37296.94 Mio. EUR |
| 4416.81 Mio. EUR |
| - |
| 0.14 |
| 38.06% |
| 113.09% |
| 5.52 EUR |
| 0.6% |
| 0.64% |
| 15.05.26 - 1.4872811€ 13.02.26 - 1.457352€ >weitere anzeigen... |
| 1 Insider verkaufte innerhalb der letzten 30 Tage Aktien im Wert von 13.548.327 Euro. |
| ELI LILLY, LILLY DEUTSCHLAND |
| 03.06.26 |
|